Autoantibodies targeting angiotensin-converting enzyme 2 are prevalent and not induced by SARS-CoV-2 infection. [PDF]
Galipeau Y+10 more
europepmc +1 more source
Comparative Risk Assessment in Hypertensive Patients With Metabolic Syndrome by Exploring Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers. [PDF]
Khan MH+6 more
europepmc +1 more source
Droplet microfluidic screening to engineer angiotensin-converting enzyme 2 (ACE2) catalytic activity. [PDF]
Okal EF, Romero PA, Heinzelman P.
europepmc +1 more source
The isolation of angiotensin-converting enzyme cDNA.
Kenneth E. Bernstein+5 more
openalex +1 more source
Rabbit and Human Angiotensin-Converting Enzyme-2: Structure and Electric Properties. [PDF]
Hristova SH, Popov TT, Zhivkov AM.
europepmc +1 more source
COVID-19 Pandemic Waves and 2024-2025 Winter Season in Relation to Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers and Amantadine. [PDF]
Puigdellívol-Sánchez A+10 more
europepmc +1 more source
Interaction of Asparagusic Acid, Asparaptines and Related Dithiolane Derivatives With Angiotensin-Converting Enzyme-2 (ACE-2): A Molecular Docking Study. [PDF]
Vergoten G, Bailly C.
europepmc +1 more source